PhD Scholar Top-up in Medicine
The Faculty of Medicine is a leading provider of medical education and medical research in Queensland, with the country's largest medical program. The four year graduate entry medical program offers an integrated, case-based curriculum including early clinical experiences. The School is a diverse enterprise operating over multiple sites, with Queensland Health and private health service providers as major partners. Geographically, the School extends throughout Queensland with major sites in Brisbane, the outer metropolitan areas, and a number of rural and remote area facilities throughout the rest of the state. The UQ medical degree is also delivered overseas in Brunei and the United States of America, emphasising the global nature of the School.
The Mater Research Institute-UQ
Mater Research Institute-UQ (MRI-UQ) is a world class institute committed to academic research and its translation into clinical care for the benefit of all. MRI-UQ is an alliance between Mater Research and UQ, providing considerable strategic and operational benefits to both parties. Mater Research brings to the alliance considerable clinical collaboration opportunites and UQ brings all its expertise as a research, education and teaching. MRI-UQ has more than 300 research staff, post graduate students and clinical researchers. There are currently 70 students undertaking a PhD MPhil or Honours program. The project supervisors are Prof Vicki Flenady, known widely as an international and national perinatal epidemiologist and is the Director of the recently established Stillbirth CRE. Prof Sailesh Kumar, a maternal and fetal medicine specialist based at the Mater Hospital Campus in South Brisbane, Queensland and is a CRE principle investigator. The Mater Mothers' Hospital in Brisbane is the largest maternity hospital in Australia with over 10,000 births each year
The NHMRC Stillbirth Centre of Research Excellence (Stillbirth CRE)
The overarching purpose of the Stillbirth CRE is to generate new knowledge that will lead to a reduction in the stillbirth rate and improve quality of care after stillbirth. With 6 stillbirths occurring in Australia every day (and over 7000 worldwide) and with major long-lasting psychological, special and financial burden to families this is an urgent issue. Many of these deaths are potentially avoidable with improved clinical care. Maternal reporting of decreased fetal movements is one of the most common reasons for unscheduled antenatal visits and these women are at increased risk of stillbirth. While DFM is often associated with fetal compromise, little is understood about the factors contributing to adverse outcome and which tests may be of benefit. The Stillbirth CRE is working closely with researchers, maternity care providers, parents and the community across a priority driven research program which has a major focus on implementing high quality research into clinical practice and commuity awareness. While are focusing on Australia with strong links internationally through the International Stillbirth Alliance, the CRE will have an impact internationally.
A PhD opportunity is available for a student with an Honours/Masters degree in a science related field to join the Stillbirth Research Group at the Mater Research. The successful candidate will be enrolled in a higher degree (PhD) by research at the University of Queensland and carry out a research project focusing on maternal reporting of decreased fetal movements and adverse pregnancy outcome. The PhD will explore factors linked with improved outcomes ( including timing of maternal reporting and clinical management) in a cohort of 300,000 women enrolled in the NHMRC funded My Baby's Movements trial https://impact.psanz.com.au/clinical-trials/mbm-trial-information/
An exciting opportunity exists for a student interested in pursuing a PhD in the area of reducing adverse pregnancy outcome, with a focus on decreased fetal movement as a predictor of stillbirth. This research group aims to undertake a detailed analysis of factors contributing to adverse outcome in women experiencing decreased fetal movements as part of a large scale trial testing the effects of a mobile phone app to raise awareness of DFM. The goal of our research is to identify strategies to reduce adverse outcome for these women. The student will join the Stillbirth Centre of Research Excellence at the Mater Research. This group is based at the Mater Health Services campus and linking with Mater Research situated at the newly opened Translational Research Institute (TRI) located at Woolloongabba, Brisbane.
Applicants must comply with the relevant entry requirements:
a) Applicants should possess a Bachelor (H1 or H2A) with honours or a Masters Degree majoring in a science related field and be eligible for a competitive living allowance scholarship (e.g. APA) to support full-time study.
b) Applicants must have a background in obstetrics/perinatology and/or clinical epidemiology
- c) Applicants must have the ability to develop skills in general research, methodology and statistics.
- d) Applicants must have excellent writing abilities, and work effectively within a multidisciplinary and international research team.
- e) Applicants must be able to enrol full-time in the PhD program.
A place in this group is contingent upon the applicant successfully attaining an external scholarship (the APA, or equivalent, valued at $26,682 per annum). APA recipients are eligible to apply for the Mater Research generous top-up scholarship schemes worth an additional $9,000 per annum. Scholarships are tax exempt for Australian citizens and residents. University fees may apply to overseas candidates.
All applicants must supply a cover letter explaining your interest in and suitability to undertake research in this area, CV, and copies of Academic Transcripts.
Further information can be obtained by emailing Assoc Prof Vicki Flenady: firstname.lastname@example.org or Prof Sailesh Kumar: email@example.com Visit our UQ Graduate School website for full terms and conditions at http://www.uq.edu.au/grad-school